Tang Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Tang Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-350,000	Closed	-$8.27M	–	138
2023 Q4	$8.27M	Buy	350,000 +150,000	+75%	+$2.67M	0.76%	35
2023 Q3	$2.98M	Buy	+200,000	New	+$2.65M	0.42%	62

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tang Capital Management's CBAY Position: Q1 2024 in Review

Tang Capital Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 350,000 shares — an estimated $8.27M sold.

Tang Capital Management first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $8.27M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Tang Capital Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Tang Capital Management sold 350,000 Cymabay Therapeutics shares in Q1 2024, an estimated $8.27M.
Tang Capital Management first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
Tang Capital Management's Cymabay Therapeutics position peaked at $8.27M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Tang Capital Management's 13F filing for Q1 2024, filed 15 May 2024.